REQUEST A DEMO
Total
USD $0.00
Search more companies

Biogenesis Bago Colombia S.A.S (Colombia)

Main Activities: Pharmacies and Drug Stores
Full name: Biogenesis Bago Colombia S.A.S Profile Updated: June 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Biogenesis Bago Colombia S.A.S is an enterprise in Colombia, with the main office in Bogota D.C.. The company operates in the Pharmacies and Drug Stores sector. Biogenesis Bago Colombia S.A.S was incorporated on August 02, 2016. It currently has a total number of 10 (2024) employees. The latest financial highlights indicate a net sales revenue increase of 246.32% in 2023. There was a total growth of 40.43% in Biogenesis Bago Colombia S.A.S’s total assets over the same period. The net profit margin of Biogenesis Bago Colombia S.A.S increased by 51.56% in 2023.

Headquarters
Cr 16 # 88 - 81 Of 204
Bogota D.C.; Bogota D.C; Postal Code: 0814

Contact Details: Purchase the Biogenesis Bago Colombia S.A.S report to view the information.

Basic Information
Total Employees:
Purchase the Biogenesis Bago Colombia S.A.S report to view the information.
Outstanding Shares:
Purchase the Biogenesis Bago Colombia S.A.S report to view the information.
Incorporation Date:
August 02, 2016
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Company Performance
Financial values in the chart are available after Biogenesis Bago Colombia S.A.S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
246.32%
Total operating revenue
246.32%
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
42.79%
Total assets
40.43%
Total equity
-41.15%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
51.56%
Return on Equity (ROE)
-42.77%
Quick Ratio
0.45%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?